Copyright Reports & Markets. All rights reserved.

Global Clinical Diagnostics PCR Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Clinical Diagnostics PCR
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Clinical Diagnostics PCR by Type
    • 1.3.1 Overview: Global Clinical Diagnostics PCR Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Clinical Diagnostics PCR Consumption Value Market Share by Type in 2023
    • 1.3.3 Infectious Disease
    • 1.3.4 Cancer
    • 1.3.5 Cardiovascular
    • 1.3.6 Genetic
    • 1.3.7 Others
  • 1.4 Global Clinical Diagnostics PCR Market by Application
    • 1.4.1 Overview: Global Clinical Diagnostics PCR Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Clinical Diagnostics PCR Market Size & Forecast
  • 1.6 Global Clinical Diagnostics PCR Market Size and Forecast by Region
    • 1.6.1 Global Clinical Diagnostics PCR Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Clinical Diagnostics PCR Market Size by Region, (2019-2030)
    • 1.6.3 North America Clinical Diagnostics PCR Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Clinical Diagnostics PCR Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Clinical Diagnostics PCR Market Size and Prospect (2019-2030)
    • 1.6.6 South America Clinical Diagnostics PCR Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Clinical Diagnostics PCR Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Clinical Diagnostics PCR Product and Solutions
    • 2.1.4 Roche Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Clinical Diagnostics PCR Product and Solutions
    • 2.2.4 Abbott Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 Agilent Technologies
    • 2.3.1 Agilent Technologies Details
    • 2.3.2 Agilent Technologies Major Business
    • 2.3.3 Agilent Technologies Clinical Diagnostics PCR Product and Solutions
    • 2.3.4 Agilent Technologies Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Agilent Technologies Recent Developments and Future Plans
  • 2.4 Qiagen
    • 2.4.1 Qiagen Details
    • 2.4.2 Qiagen Major Business
    • 2.4.3 Qiagen Clinical Diagnostics PCR Product and Solutions
    • 2.4.4 Qiagen Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Qiagen Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Clinical Diagnostics PCR Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 DAAN Gene
    • 2.6.1 DAAN Gene Details
    • 2.6.2 DAAN Gene Major Business
    • 2.6.3 DAAN Gene Clinical Diagnostics PCR Product and Solutions
    • 2.6.4 DAAN Gene Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 DAAN Gene Recent Developments and Future Plans
  • 2.7 Hologic
    • 2.7.1 Hologic Details
    • 2.7.2 Hologic Major Business
    • 2.7.3 Hologic Clinical Diagnostics PCR Product and Solutions
    • 2.7.4 Hologic Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Hologic Recent Developments and Future Plans
  • 2.8 Diagenode
    • 2.8.1 Diagenode Details
    • 2.8.2 Diagenode Major Business
    • 2.8.3 Diagenode Clinical Diagnostics PCR Product and Solutions
    • 2.8.4 Diagenode Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Diagenode Recent Developments and Future Plans
  • 2.9 Bio-Rad
    • 2.9.1 Bio-Rad Details
    • 2.9.2 Bio-Rad Major Business
    • 2.9.3 Bio-Rad Clinical Diagnostics PCR Product and Solutions
    • 2.9.4 Bio-Rad Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bio-Rad Recent Developments and Future Plans
  • 2.10 Takara Bio
    • 2.10.1 Takara Bio Details
    • 2.10.2 Takara Bio Major Business
    • 2.10.3 Takara Bio Clinical Diagnostics PCR Product and Solutions
    • 2.10.4 Takara Bio Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Takara Bio Recent Developments and Future Plans
  • 2.11 Meridian Bioscience
    • 2.11.1 Meridian Bioscience Details
    • 2.11.2 Meridian Bioscience Major Business
    • 2.11.3 Meridian Bioscience Clinical Diagnostics PCR Product and Solutions
    • 2.11.4 Meridian Bioscience Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Meridian Bioscience Recent Developments and Future Plans
  • 2.12 Toyobo
    • 2.12.1 Toyobo Details
    • 2.12.2 Toyobo Major Business
    • 2.12.3 Toyobo Clinical Diagnostics PCR Product and Solutions
    • 2.12.4 Toyobo Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Toyobo Recent Developments and Future Plans
  • 2.13 SSI Diagnostica
    • 2.13.1 SSI Diagnostica Details
    • 2.13.2 SSI Diagnostica Major Business
    • 2.13.3 SSI Diagnostica Clinical Diagnostics PCR Product and Solutions
    • 2.13.4 SSI Diagnostica Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 SSI Diagnostica Recent Developments and Future Plans
  • 2.14 Genekam
    • 2.14.1 Genekam Details
    • 2.14.2 Genekam Major Business
    • 2.14.3 Genekam Clinical Diagnostics PCR Product and Solutions
    • 2.14.4 Genekam Clinical Diagnostics PCR Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Genekam Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Clinical Diagnostics PCR Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Clinical Diagnostics PCR by Company Revenue
    • 3.2.2 Top 3 Clinical Diagnostics PCR Players Market Share in 2023
    • 3.2.3 Top 6 Clinical Diagnostics PCR Players Market Share in 2023
  • 3.3 Clinical Diagnostics PCR Market: Overall Company Footprint Analysis
    • 3.3.1 Clinical Diagnostics PCR Market: Region Footprint
    • 3.3.2 Clinical Diagnostics PCR Market: Company Product Type Footprint
    • 3.3.3 Clinical Diagnostics PCR Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Clinical Diagnostics PCR Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Clinical Diagnostics PCR Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Clinical Diagnostics PCR Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Clinical Diagnostics PCR Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Clinical Diagnostics PCR Consumption Value by Type (2019-2030)
  • 6.2 North America Clinical Diagnostics PCR Consumption Value by Application (2019-2030)
  • 6.3 North America Clinical Diagnostics PCR Market Size by Country
    • 6.3.1 North America Clinical Diagnostics PCR Consumption Value by Country (2019-2030)
    • 6.3.2 United States Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Clinical Diagnostics PCR Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Clinical Diagnostics PCR Consumption Value by Type (2019-2030)
  • 7.2 Europe Clinical Diagnostics PCR Consumption Value by Application (2019-2030)
  • 7.3 Europe Clinical Diagnostics PCR Market Size by Country
    • 7.3.1 Europe Clinical Diagnostics PCR Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 7.3.3 France Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Clinical Diagnostics PCR Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Clinical Diagnostics PCR Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Clinical Diagnostics PCR Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Clinical Diagnostics PCR Market Size by Region
    • 8.3.1 Asia-Pacific Clinical Diagnostics PCR Consumption Value by Region (2019-2030)
    • 8.3.2 China Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 8.3.5 India Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Clinical Diagnostics PCR Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Clinical Diagnostics PCR Consumption Value by Type (2019-2030)
  • 9.2 South America Clinical Diagnostics PCR Consumption Value by Application (2019-2030)
  • 9.3 South America Clinical Diagnostics PCR Market Size by Country
    • 9.3.1 South America Clinical Diagnostics PCR Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Clinical Diagnostics PCR Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Clinical Diagnostics PCR Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Clinical Diagnostics PCR Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Clinical Diagnostics PCR Market Size by Country
    • 10.3.1 Middle East & Africa Clinical Diagnostics PCR Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Clinical Diagnostics PCR Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Clinical Diagnostics PCR Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Clinical Diagnostics PCR Market Drivers
  • 11.2 Clinical Diagnostics PCR Market Restraints
  • 11.3 Clinical Diagnostics PCR Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Clinical Diagnostics PCR Industry Chain
  • 12.2 Clinical Diagnostics PCR Upstream Analysis
  • 12.3 Clinical Diagnostics PCR Midstream Analysis
  • 12.4 Clinical Diagnostics PCR Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Clinical Diagnostics PCR market size was valued at USD 8864.4 million in 2023 and is forecast to a readjusted size of USD 13440 million by 2030 with a CAGR of 6.1% during review period.
    Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
    A significant driver in the clinical diagnostics PCR (Polymerase Chain Reaction) market is the increasing demand for accurate and rapid molecular diagnostic tests, particularly in infectious disease management and genetic testing. PCR technology offers high sensitivity and specificity, making it indispensable for disease detection and monitoring. However, a notable challenge in this market is the need for advanced assay development and standardization. Ensuring the reliability and reproducibility of PCR-based tests across different laboratories and diagnostic platforms poses a challenge. Manufacturers and healthcare professionals must collaborate to address these challenges, enabling consistent and accurate PCR-based clinical diagnostics to meet the evolving demands of modern healthcare.
    The Global Info Research report includes an overview of the development of the Clinical Diagnostics PCR industry chain, the market status of Hospitals (Infectious Disease, Cancer), Clinics (Infectious Disease, Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Clinical Diagnostics PCR.
    Regionally, the report analyzes the Clinical Diagnostics PCR markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Clinical Diagnostics PCR market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Clinical Diagnostics PCR market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Clinical Diagnostics PCR industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Infectious Disease, Cancer).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Clinical Diagnostics PCR market.
    Regional Analysis: The report involves examining the Clinical Diagnostics PCR market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Clinical Diagnostics PCR market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Clinical Diagnostics PCR:
    Company Analysis: Report covers individual Clinical Diagnostics PCR players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Clinical Diagnostics PCR This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Clinical Diagnostics PCR. It assesses the current state, advancements, and potential future developments in Clinical Diagnostics PCR areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Clinical Diagnostics PCR market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Clinical Diagnostics PCR market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Infectious Disease
    Cancer
    Cardiovascular
    Genetic
    Others
    Market segment by Application
    Hospitals
    Clinics
    Others
    Market segment by players, this report covers
    Roche
    Abbott
    Agilent Technologies
    Qiagen
    Thermo Fisher Scientific
    DAAN Gene
    Hologic
    Diagenode
    Bio-Rad
    Takara Bio
    Meridian Bioscience
    Toyobo
    SSI Diagnostica
    Genekam
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Clinical Diagnostics PCR product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Clinical Diagnostics PCR, with revenue, gross margin and global market share of Clinical Diagnostics PCR from 2019 to 2024.
    Chapter 3, the Clinical Diagnostics PCR competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Clinical Diagnostics PCR market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Diagnostics PCR.
    Chapter 13, to describe Clinical Diagnostics PCR research findings and conclusion.

    Buy now